Addiction concealment is the default for roughly a quarter to half of people with substance use disorders — driven by stigma, fear of judgment, and shame. A 2024 study of OUD patients in Pennsylvania found that 46% worried about what others would say if they sought treatment, and 78% felt they should be able to handle their substance use on their own (PMC11354585). A NSDUH-based analysis found that 22.7% of adults with unmet treatment need cited stigma specifically — not wanting others to know, concern about community judgment, or fear of employment consequences — as a barrier to seeking help (PMC5754000). These are the populations most likely to have extended concealment patterns, keeping addiction hidden from family members who might otherwise have supported treatment entry.
The clinical evidence on disclosure outcomes is consistently directional, if not quantified as direct regret measures. A Nebraska population survey found that 72.5% of adults anticipated turning to family or friends for support if they had a substance problem, and that people who had previously given emotional support to family were over four times more likely to anticipate receiving it back — a structural finding suggesting that family disclosure unlocks a recovery resource that concealment forecloses (PMC9856213). Research synthesising multiple studies identifies family emotional support as generally beneficial for reducing drug use, though with complexity: disclosers sometimes experience conflicting emotions of guilt or pressure alongside support. Qualitative data show that both stigmatising and supportive reactions occur after disclosure, and that caregivers themselves experience associative stigma — a factor that may discourage disclosure without eliminating the case for it.
Under Gilovich and Medvec’s temporal framework, the regret asymmetry here arises from a visibility imbalance: people who disclosed and experienced difficult family reactions can see clearly that they gained support or at least honesty, even if the initial reaction was painful. People who concealed for years can see, in retrospect, the delayed treatment entry, the energy spent maintaining the secret, the relationships that atrophied through distance, and the crises that eventually forced disclosure anyway. The counterfactual is more costly and more visible for the inaction group. The 20-point proxy gap is narrower than many other entries in this collection — reflecting the genuine uncertainty in the evidence base — but the directional signal from both the clinical and social literature is consistent: sustained concealment from family carries predictable costs that most people in long-term recovery report wishing they had avoided sooner.